These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36434332)

  • 1. Clinical use of cardiac 18 F-FDG viability PET: a retrospective study of 44 patients undergoing post-test revascularization.
    Luong TV; Ebbehoj A; Kjaerulff MLG; Nielsen R; Nielsen PH; Christiansen EH; Tolbod LP; Søndergaard E; Gormsen LC
    Int J Cardiovasc Imaging; 2022 Nov; 38(11):2447-2458. PubMed ID: 36434332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemic heart failure mortality is not predicted by cardiac insulin resistance but by diabetes per se and coronary flow reserve: A retrospective dynamic cardiac
    Luong TV; Pedersen MGB; Kjærulff MLBG; Madsen S; Lauritsen KM; Tolbod LP; Søndergaard E; Gormsen LC
    Metabolism; 2021 Oct; 123():154862. PubMed ID: 34375646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reverse Mismatch Pattern in Cardiac 18F-FDG Viability PET/CT Is Not Associated With Poor Outcome of Revascularization: A Retrospective Outcome Study of 91 Patients With Heart Failure.
    Hansen AK; Gejl M; Bouchelouche K; Tolbod LP; Gormsen LC
    Clin Nucl Med; 2016 Oct; 41(10):e428-35. PubMed ID: 27488429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of diabetes mellitus on prediction of clinical outcome after coronary revascularization by 18F-FDG SPECT in patients with ischemic left ventricular dysfunction.
    Schinkel AF; Poldermans D; Rizzello V; van Domburg RT; Valkema R; Elhendy A; Biagini E; Krenning EP; Simoons ML; Bax JJ
    J Nucl Med; 2006 Jan; 47(1):68-73. PubMed ID: 16391189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic performance of quantitative PET tools for stratification of patients with ischemic cardiomyopathy undergoing myocardial viability assessment.
    Santana CA; Faber TL; Soler-Peter M; Sanyal R; Esteves FP; Ornelas M; Folks RD; Verdes L; Santana LF; Candell-Riera J; Garcia EV
    Nucl Med Commun; 2008 Nov; 29(11):970-81. PubMed ID: 18836375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of
    Moody JB; Hiller KM; Lee BC; Poitrasson-Rivière A; Corbett JR; Weinberg RL; Murthy VL; Ficaro EP
    J Nucl Cardiol; 2019 Apr; 26(2):374-386. PubMed ID: 30809755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial.
    D'Egidio G; Nichol G; Williams KA; Guo A; Garrard L; deKemp R; Ruddy TD; DaSilva J; Humen D; Gulenchyn KY; Freeman M; Racine N; Benard F; Hendry P; Beanlands RS;
    JACC Cardiovasc Imaging; 2009 Sep; 2(9):1060-8. PubMed ID: 19761983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between preoperative viability and postoperative improvement in LVEF and heart failure symptoms.
    Bax JJ; Visser FC; Poldermans D; Elhendy A; Cornel JH; Boersma E; Valkema R; Van Lingen A; Fioretti PM; Visser CA
    J Nucl Med; 2001 Jan; 42(1):79-86. PubMed ID: 11197985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability.
    Ghesani M; Depuey EG; Rozanski A
    Echocardiography; 2005 Feb; 22(2):165-77. PubMed ID: 15693785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of functional recovery after revascularization in patients with coronary artery disease and left ventricular dysfunction by gated FDG-PET.
    Slart RH; Bax JJ; van Veldhuisen DJ; van der Wall EE; Dierckx RA; de Boer J; Jager PL
    J Nucl Cardiol; 2006; 13(2):210-9. PubMed ID: 16580957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of quantitative assessment of right ventricular glucose metabolism in patients with heart failure with reduced ejection fraction.
    Tsai SY; Wu YW; Wang SY; Shiau YC; Chiu KM; Tsai HY; Lee CL; Hsu JC; Tu CM; Lin HH; Huang SH
    Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2601-2609. PubMed ID: 31410543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of contrast-enhanced MRI with (18)F-FDG PET/201Tl SPECT in dysfunctional myocardium: relation to early functional outcome after surgical revascularization in chronic ischemic heart disease.
    Wu YW; Tadamura E; Yamamuro M; Kanao S; Marui A; Tanabara K; Komeda M; Togashi K
    J Nucl Med; 2007 Jul; 48(7):1096-103. PubMed ID: 17607039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-carbohydrate diet versus euglycemic hyperinsulinemic clamp for the assessment of myocardial viability with 18F-fluorodeoxyglucose-PET: a pilot study.
    Soares J; Rodrigues Filho F; Izaki M; Giorgi MC; Catapirra RM; Abe R; Vinagre CG; Cerri GG; Meneghetti JC
    Int J Cardiovasc Imaging; 2014 Feb; 30(2):415-23. PubMed ID: 24253855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial viability assessment by PET: (82)Rb defect washout does not predict the results of metabolic-perfusion mismatch.
    Stankewicz MA; Mansour CS; Eisner RL; Churchwell KB; Williams BR; Sigman SR; Streeter J; Patterson RE
    J Nucl Med; 2005 Oct; 46(10):1602-9. PubMed ID: 16204709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial perfusion reserve after a PET-driven revascularization procedure: a strong prognostic factor.
    Slart RH; Zeebregts CJ; Hillege HL; de Sutter J; Dierckx RA; van Veldhuisen DJ; Zijlstra F; Tio RA
    J Nucl Med; 2011 Jun; 52(6):873-9. PubMed ID: 21571798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography using(18)F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community Concerted Action Multicenter study on use of(18)F-fluoro-deoxyglucose Positron Emission Tomography for the Detection of Myocardial Viability.
    Gerber BL; Ordoubadi FF; Wijns W; Vanoverschelde JL; Knuuti MJ; Janier M; Melon P; Blanksma PK; Bol A; Bax JJ; Melin JA; Camici PG
    Eur Heart J; 2001 Sep; 22(18):1691-701. PubMed ID: 11511119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of myocardial hibernation, scar, and angiographic collateral flow in ischemic cardiomyopathy with coronary chronic total occlusion.
    Wang L; Lu MJ; Feng L; Wang J; Fang W; He ZX; Dou KF; Zhao SH; Yang MF
    J Nucl Cardiol; 2019 Oct; 26(5):1720-1730. PubMed ID: 29516366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18-Fluorodeoxyglucose imaging with positron emission tomography and single photon emission computed tomography: cardiac applications.
    Bax JJ; Patton JA; Poldermans D; Elhendy A; Sandler MP
    Semin Nucl Med; 2000 Oct; 30(4):281-98. PubMed ID: 11105929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.